Article info

Original research
Antibody-induced erythrophagocyte reprogramming of Kupffer cells prevents anti-CD40 cancer immunotherapy-associated liver toxicity

Authors

  1. Correspondence to Dr Florence Vallelian; florence.vallelian{at}usz.ch
View Full Text

Citation

Pfefferlé M, Dubach IL, Buzzi RM, et al
Antibody-induced erythrophagocyte reprogramming of Kupffer cells prevents anti-CD40 cancer immunotherapy-associated liver toxicity

Publication history

  • Accepted December 1, 2022
  • First published January 2, 2023.
Online issue publication 
December 07, 2023

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.